Subsidiary Dong-il Interlining's Capital Increase Payment Date Postponed to June 15


  • Correction filing: Payment date for subsidiary Dong-il Interlining's capital increase (debt-to-equity swap) postponed from May 15, 2026 to June 15, 2026
  • Reason: Processing delay with Vietnamese authorities
  • Purpose: Debt repayment of 2.98 billion won (USD 2,000,000 equity conversion)
  • Subsidiary total assets: 9.9 billion won (8.31% of parent's consolidated assets)

KOSPI Filing Information


  • Filing: [Correction of Description] Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary)
  • Company: GeneOne Life Science (011000)
  • Submission: GeneOne Life Science, Inc.
  • Receipt: 05-15-2026
  • Under KRX KOSPI Market Division